BenzingaBenzinga Japan
BenzingaBenzinga Japan
BenzingaBenzinga Japan
月曜日, 9 28

Praxis Precision Medicines Inc

PRAXNASDAQ
Trade with Public
Trade with Public
$280.78
-1.01-0.36%
近くで: Sep 24, 5:00 PM EST
$280.78
-1.01-0.36%
プレマーケット: 3:00 AM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Praxis Precision Medicine Analyst Price Targets

Wall Street analyst price targets and consensus rating for Praxis Precision Medicine (PRAX).

Price Target Range — 10 Quarters

Analyst Consensus — 17 Analysts

16Buy
1Sell
Consensus RatingBuy# Analysts17Avg. Consensus PT$539Upside to Avg. PT+91.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →
DateFirmAnalystActionRating ChangePrice Target
Sep 24, 2026HC Wainwright & Co.Douglas TsaoMaintainedBuy$1201
Sep 24, 2026NeedhamAmi FadiaMaintainedBuy$582
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1201 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $1201 price target.
Benzinga Newsdesk

PRO
Needham Reiterates Buy on Praxis Precision Medicine, Maintains $582 Price Target

Needham analyst Ami Fadia reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $582 price target.
Benzinga Newsdesk

PRO
Goldman Sachs Maintains Buy on Praxis Precision Medicine, Raises Price Target to $575

Goldman Sachs analyst Kevin Strang maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $470 to $575.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $462

RBC Capital analyst Leonid Timashev maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and raises the price target from $449 to $462.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on Praxis Precision Medicine, Raises Price Target to $362

Wells Fargo analyst Benjamin Burnett maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Equal-Weight and raises the price target from $323 to $362.
Benzinga Newsdesk

PRO
Needham Maintains Buy on Praxis Precision Medicine, Raises Price Target to $582

Needham analyst Ami Fadia maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $575 to $582.
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

市場データ提供元 Benzinga API

BenzingaBenzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved